Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftidoren versus levofloxacin for acute exacerbations of chronic bronchitis
2011-000531-88Phase 4Completed
- Sponsor
- IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic bronchitis (CB) comparing Ceftidoren arm with Levofloxacin control arm (2 arms). Primary endpoints: Speed of reduction of inflammatory biomarkers and Clinical efficacy at test of cure. Started May 2011; status: completed.
02
Drugs
cefditorenlevofloxacin
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on 2011-000531-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000531-88.